EuroIntervention has released multiple articles in conjunction with EuroPCR 2023. Along with 3 major simultaneous publications, we have 3 Late Breaking Trials and 2 abstracts.
Tuesday 16 May
- Stepwise provisional versus systematic culotte for stenting of true coronary bifurcation lesions: five-year follow-up of the multicentre randomised EBC TWO Trial from Sandeep Arunothayaraj et al.
Wednesday 17 May
- A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3G): one-year results of the BIOMAG-1 first-in-human study from Michael Haude et al.
Thursday 18 May
- Transcatheter aortic valve implantation with the Evolut platform for bicuspid aortic valve stenosis: the international, multicentre, prospective BIVOLUTX registry from Didier Tchetche et al.
Friday 19 May
- Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial from Amerjeet Singh Banning et al.
- Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR) from Susheel K. Kodali et al.